A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort
Abstract
Predictive models that take race into account like the Prostate Cancer Prevention Trial Risk Calculator 2.0 (PCPT RC) and the new Prostate Biopsy Collaborative Group (PBCG) RC have been developed to equitably mitigate the overdiagnosis of prostate specific antigen (PSA) screening. Few studies have compared the performance of both calculators across racial groups.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Nov 27, 2019
- Source ID
- 10.1186/s12894-019-0553-6
Entities
People
- Adam B Murphy
- Borko Jovanovic
- Courtney M.P. Hollowell
- Edward M. Schaeffer
- Irene B. Helenowski
- Maria Ruden
- Oluwarotimi S Nettey
- Peter H Gann
- Pooja Gogana
- Rick A. Kittles
- Roohollah Sharifi
- Samuel Carbunaru
Organizations
- Defense Health Agency
- National Cancer Institute